A comparison of ER+ breast cancer cell lines showed that TRIM33 levels were highest in MCF-7 (Figure 2A); thus, MCF-7 cells were used to generate two stable shRNA knockdown polyclonal models (#5 and #6, Figure S2). This evidence concerns the gene TRIM33 and breast cancer.